A French startup has received a CE mark for a small, inflatable device designed to apply gentle pressure and halt nosebleeds.

Thirty years ago, when the field of tissue engineering beginning to coalesce, experts predicted we were just a couple decades away from creating brand-new organs for patients. After all, replacement parts made of plastic or metal had become a reality—just ask the millions of people living with knee or hip replacements.

Virtual Reality for Designing Drugs – University of Bristol Researchers

The second HIV infected person cured

Bacteria May Cause Diabetes 2 – Says, Scientists

CRISPR-Cas12b for Plant Genome Engineering

A team of researchers at the University of Minnesota Medical School recently proved the ability to grow human-derived blood vessels in a pig–a novel approach that has the potential for providing unlimited human vessels for transplant purposes. Because these vessels were made with patient-derived skin cells, they are less likely to be rejected by the recipient, helping patients potentially avoid the need for life-long, anti-rejection drugs.

Non-small cell lung cancer (NSCLC) is the most commonly diagnosed cancer, and the leading cause of cancer death worldwide. More than half of NSCLC patients die after developing metastases. There are no tests currently that would allow doctors to identify patients where more aggressive therapy could reduce mortality. Researchers at Tulane University have identified a protein on tumor-derived extracellular vesicles that indicates if a NSCLC tumor is likely to metastasize, according to a new study in Science Advances.

Researchers at the University of Campinas (UNICAMP) in São Paulo State, Brazil, have developed a computer program that analyzes molecules in blood plasma to search for biomarkers that identify individuals who are at risk of becoming overweight and developing obesity-related diseases.

Bone marrow plasma cells produce antibodies. These comprise two long and two short protein chains. The pathological proliferation of plasma cells can lead to an overproduction of the short chains. These associate to fibrils and deposit in organs. The result is fatal organ failure. A research team from the Technical University of Munich (TUM) and Heidelberg University has now identified the mutation behind the disease in a patient.